Physician profile
Ali El Atat
NPI 1487853008
$482,281.18
in general payments reported to CMS, 2019-2025
50 companies · $124K in 2025
The $124K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $20K · 2021: $34K · 2022: $51K · 2023: $113K · 2024: $125K · 2025: $124K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $323K · Food and Beverage: $23K · Travel and Lodging: $9,692 · Consulting Fee: $6,045 · Education: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $323,246.60 |
| Food and Beverage | $22,502.67 |
| Travel and Lodging | $9,692.30 |
| Consulting Fee | $6,045.00 |
| Education | $223.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $285,159.76 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $114,427.93 | 2019-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Regeneron Healthcare Solutions, INC. | $38,583.70 | 2019-2025 | Dupixent |
| Genzyme Corporation | $19,532.77 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $8,625.30 | 2019-2025 | Spiriva Respimat, Ofev, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $4,615.53 | 2019-2025 | |
| Genentech USA, INC. | $1,942.64 | 2019-2025 | Xolair |
| Actelion Pharmaceuticals US, INC. | $1,299.67 | 2019-2025 | Opsumit, Uptravi |
| Insmed, INC. | $1,070.89 | 2019-2025 | Arikayce, Brinsupri |
| Amgen INC. | $815.44 | 2021-2025 | Tezspire, Tavneos, Repatha |
| Janssen Pharmaceuticals, INC | $703.40 | 2021-2024 | Xarelto |
| Pfizer INC. | $467.92 | 2019-2025 | |
| Lilly USA, LLC | $397.74 | 2019-2025 | Mounjaro, Zepbound |
| Mallinckrodt Hospital Products INC. | $366.81 | 2021-2025 | Acthar |
| Advanced Respiratory, INC | $292.70 | 2019-2021 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $278.88 | 2025 | Ohtuvayre |
| Paratek Pharmaceuticals, INC. | $272.18 | 2023-2025 | Nuzyra, Xhance |
| Biohaven Pharmaceutical Holding Company Ltd. | $267.82 | 2022 | |
| Ani Pharmaceuticals, INC. | $235.17 | 2023-2024 | Purified Cortrophin Gel |
| Electromed, INC. | $229.71 | 2019-2022 | |
| Inogen, INC. | $218.69 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Merck Sharp & Dohme LLC | $199.76 | 2019-2023 | Verquvo |
| United Therapeutics Corporation | $189.99 | 2019-2025 | Tyvaso, Tyvaso |
| Teva Pharmaceuticals USA, INC. | $185.42 | 2019-2022 | |
| Philips North America LLC | $173.66 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $171.55 | 2022-2024 | Aralast |
| Shield Therapeutics INC | $165.77 | 2023-2025 | Accrufer |
| Abbvie INC. | $125.00 | 2025 | |
| Mylan Specialty L.P. | $121.67 | 2022-2023 | Yupelri |
| Ge Healthcare | $104.19 | 2022 | |
| Novartis Pharmaceuticals Corporation | $103.51 | 2020-2024 | |
| Sanofi-Aventis U.S. LLC | $99.99 | 2025 | |
| Optinose US, INC. | $95.22 | 2024-2025 | |
| Baxter Healthcare | $83.18 | 2023-2024 | Hillrom - Vest System Model 105 Home Care |
| Currax Pharmaceuticals LLC | $78.46 | 2021-2022 | |
| Gilead Sciences, INC. | $78.17 | 2019 | |
| Exact Sciences Corporation | $78.00 | 2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $77.74 | 2022-2024 | Rybelsus, Ozempic |
| Circassia INC. | $71.37 | 2019-2021 | |
| Biogen, INC. | $57.24 | 2024-2025 | Skyclarys |
| Esperion Therapeutics, INC. | $43.66 | 2024-2025 | Nexletol |
| Olympus America INC. | $29.01 | 2020 | |
| Axsome Therapeutics, INC. | $26.70 | 2023 | Sunosi |
| Hikma Pharmaceuticals USA | $20.98 | 2022 | |
| Inspire Medical Systems, INC. | $20.85 | 2025 | Inspire |
| Intra-Sana Laboratories | $20.00 | 2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Itamar Medical INC | $19.71 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.20 | 2024 | Xifaxan |
| Horizon Therapeutics Plc | $16.53 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali El Atat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.